Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$1.03 - $1.24 $354,583 - $426,877
-344,256 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$1.05 - $2.2 $361,468 - $757,363
344,256 New
344,256 $48,000

Others Institutions Holding ENTX

About Entera Bio Ltd.


  • Ticker ENTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,809,900
  • Market Cap $65.1M
  • Description
  • Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed ...
More about ENTX
Track This Portfolio

Track Dld Asset Management, LP Portfolio

Follow Dld Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dld Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Dld Asset Management, LP with notifications on news.